Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14804
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBoonyaleephan S.
dc.date.accessioned2021-04-05T04:31:56Z-
dc.date.available2021-04-05T04:31:56Z-
dc.date.issued2008
dc.identifier.issn1252208
dc.identifier.other2-s2.0-58949090429
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14804-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-58949090429&partnerID=40&md5=2fd3b1ec03ed2ea01f81dd35fadb3257
dc.description.abstractObjective: Describe bilateral acute onset myopia and angle-closure glaucoma as ocular adverse effects of topiramate. Case Report: A 23 year-old woman developed bilateral severe blurred vision seven days after initiating therapy with topiramate. Her visual acuity was counting fingers in both eyes. Intraocular pressures were 33 mmHg and 32 mmHg in the right and left eyes, respectively, with conjunctival chemosis, corneal edema, shallow anterior chambers, and closed angles. Her refraction was -7.50 diopters in both eyes. The symptoms and clinical findings resolved completely upon discontinuation of topiramate and administration of antiglaucoma drugs. Conclusion: Topiramate use can result in acute bilateral angle-closure glaucoma and myopia, which are usually reversible upon cessation of the drug. Visual outcome is usually good and the episode resolves within a few weeks. Thus, it is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.
dc.subjectacetazolamide
dc.subjectamitriptyline
dc.subjectantiglaucoma agent
dc.subjectglycerol
dc.subjectmefenamic acid
dc.subjectprednisolone acetate
dc.subjectpropranolol derivative
dc.subjecttimolol maleate
dc.subjecttopiramate
dc.subjectacetazolamide
dc.subjectanticonvulsive agent
dc.subjectantihypertensive agent
dc.subjectcryoprotective agent
dc.subjectdrug derivative
dc.subjectfructose
dc.subjectglycerol
dc.subjecttimolol
dc.subjecttopiramate
dc.subjectadult
dc.subjectanterior eye chamber
dc.subjectarticle
dc.subjectbiomicroscopy
dc.subjectblurred vision
dc.subjectcase report
dc.subjectchemosis
dc.subjectclosed angle glaucoma
dc.subjectcornea edema
dc.subjectdrug withdrawal
dc.subjecteye examination
dc.subjecteye pain
dc.subjecteye refraction
dc.subjectfemale
dc.subjecthuman
dc.subjectintraocular pressure
dc.subjectmigraine
dc.subjectmyopia
dc.subjectphotography
dc.subjectside effect
dc.subjectvisual acuity
dc.subjectacute disease
dc.subjectchemically induced disorder
dc.subjectclosed angle glaucoma
dc.subjectdrug effect
dc.subjectmyopia
dc.subjectrisk factor
dc.subjectAcetazolamide
dc.subjectAcute Disease
dc.subjectAdult
dc.subjectAnticonvulsants
dc.subjectAntihypertensive Agents
dc.subjectCryoprotective Agents
dc.subjectFemale
dc.subjectFructose
dc.subjectGlaucoma, Angle-Closure
dc.subjectGlycerol
dc.subjectHumans
dc.subjectIntraocular Pressure
dc.subjectMyopia
dc.subjectRisk Factors
dc.subjectTimolol
dc.titleBilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 91, No.12 (2008), p.1904-1908
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.